Statin-induced Myopathy
📧 Sign up to get email alerts when something new happens for Statin-induced Myopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Metabolic and Mitochondrial Changes in Statin-Induced Myopathy
This completed clinical trial investigates metabolic and mitochondrial changes associated with statin-induced myopathy.
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Pharmacogenomic Modulators of Impaired Exercise Adaptation in Statin Users [NA]
Clinical trial update exploring pharmacogenomic factors that influence exercise adaptation in people taking statins, focusing on statin-rela…
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Dantrolene in Statin-induced Myopathy [Phase 2, Phase 3]
Dantrolene is being studied in Phase 2 and Phase 3 trials for statin-induced myopathy; recruitment has not yet begun.
-
CLINICAL_TRIALS trial_result · 2017-03-15Clinical Trial Update: Evaluation of Patients With Statin Myopathy Using an N of 1 Trial Design [NA]
A completed study used an N-of-1 trial design to evaluate statin-induced myopathy in patients. The update summarizes the trial's design and …
-
CLINICAL_TRIALS withdrawal · 2015-05-22Clinical Trial Update: Muscle Characteristics Associated With Statin Therapy [NA]
A clinical trial evaluating muscle characteristics associated with statin therapy has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2015-04-07Clinical Trial Update: Vitamin D Replacement in Statin-Induced Myopathy [NA]
The clinical trial evaluating vitamin D replacement for statin-induced myopathy has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Investigations on Differences in Atorvastatin Metabolites Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity [Phase 4]
Phase 4 trial evaluating differences in atorvastatin metabolite ratios as a diagnostic tool to detect atorvastatin-induced myotoxicity; the …
-
CLINICAL_TRIALS trial_result · 2012-05-10Clinical Trial Update: Differences in Atorvastatin Metabolite Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity [Phase 4]
Phase 4 clinical trial update evaluating whether differences in atorvastatin metabolite ratios can diagnose atorvastatin-induced myotoxicity…